Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Leukaemias myeloid NEC
ADR ID BADD_A02513
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.01      Leukaemias
16.01.08      Leukaemias myeloid NEC
01      Blood and lymphatic system disorders
01.10      Leukaemias
01.10.08      Leukaemias myeloid NEC
Description Not Available
MedDRA Code 10024309
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00194Azacitidine0.000783%
BADD_D00195Azathioprine0.000313%
BADD_D00474Cisplatin0.000112%
BADD_D00494Clodronic acid--
BADD_D00549Cyclophosphamide--
BADD_D00589Dasatinib0.000448%
BADD_D00699Docetaxel--
BADD_D00723Doxorubicin--
BADD_D00773Entacapone0.002744%
BADD_D00871Felbamate--
BADD_D00914Fludarabine0.000112%
BADD_D01110Hydroxyurea0.000112%
BADD_D01136Imatinib0.005261%
BADD_D01253Lenalidomide0.000241%
BADD_D01418Methotrexate0.000114%
BADD_D01567Nilotinib0.003246%
BADD_D01601Olaparib0.000168%
BADD_D01609Omacetaxine mepesuccinate0.000112%
BADD_D01799Ponatinib0.001063%
BADD_D01978Ruxolitinib0.000274%
BADD_D02002Selegiline--
BADD_D02150Temozolomide--
BADD_D02203Thiotepa--
BADD_D02345Venetoclax0.000224%
BADD_D02517Enasidenib0.000246%
The 1th Page    1    Total 1 Pages